Title
Category
Credits
Event date
Cost
  • Primary Care
  • Acute Care
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$15.00
0.75 NAPNAP Pharmacology Contact Hour, and 0.75 Psychopharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 7.5$ for NAPNAP Members. For non- members, this continuing education activity rate is 15$. An extensive review will provide the participant with up-to-date information about commonly used antidepressants and atypical antipsychotics.
  • Primary Care
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$30.00
1.25 NAPNAP contact hour, of which 0.25 is Pharmacology and 0.25 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 15$ for NAPNAP Members. For non- members, this continuing education activity rate is 30$. The course will review disruptive behavior disorders in childhood, including oppositional defiant disorder and conduct disorder. Case studies will include “normal-but-challenging” child behaviors as well as cases delineating diagnostic criteria for these disorders. The presenter will introduce behavioral therapy approaches, including Parent Child Interaction Therapy.
  • Primary Care
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
  • Contact hours
$10.00
1.0 NAPNAP Contact Hour 0.5 Pharmacology Hours 1.0 Psychopharmacology 0.5 controlled substance. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. The purpose of this presentation is to have a case-based discussion to increase primary care provider (PCP) confidence in caring for children with ADHD symptoms who have other co-morbidities and those who do not have successful clinical response to first medication use. Included in the discussion are the diagnostic criteria for ADHD, anxiety, autism and explosive anger disorder; the guidelines for screening and diagnosis; and discussion of the pharmacologic therapies that reduce core symptoms of the conditions. The presenter will address controversies in prescribing and the realities of clinical primary care management.